Rethinking hair loss treatment
From BioSpace · · 21 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients.
Host
Jennifer C. Smith-Parker (https://www.linkedin.com/in/jennifersmithparker/), Director of Insights, BioSpace
Guests
Daniel Gil (https://www.linkedin.com/in/daniel-gil-165067aa/), CEO, Pelage Pharmaceuticals
Francisco Ramírez-Valle (https://www.linkedin.com/in/francisco-ramirez-valle/), Senior Vice President, Immunology Discovery, Eli Lilly
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.